AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
California, USA-based drug developer Xoma and Japan's Takeda have expanded the scope of their antibody development deal, increasing the number therapeutic programs on which they will collaborate. The partnership, which was established late last year (Marketletter November 6, 2006), uses the US firm's large phage display library and ...